Area of Interest: Latin America
What we are looking for:
|
For Latin American markets, our focus lies with products in late stage clinical development, ready to be filed, or marketed.
|
|
Read our recent press releases on Grünenthal partnering projects in Latin America
-
PR_Grünenthal introduces Latin America’s most modern women’s health products plant
-
Press Release Tecnandina GMP Inspection
-
Grünenthal and AstraZeneca enter into license agreement for lesinurad in Europe and Latin America
-
Grünenthal announces exclusive license agreement for commercialization of innovative surgical glue in the EU and Latin America
-
Grünenthal Group to Acquire Almirall de Mexico, S.A. de C.V.
-
Grünenthal completes acquisition of Empresas Andrómaco
-
Grünenthal launches public tender offer to the shareholders of Empresas Andrómaco
-
Grünenthal takes over a product portfolio of BIOGEN® LABORATORIOS
-
The Grünenthal Group Enters into Exclusive Agreement with Horizon Pharma for Commercialization of DUEXIS® in Latin America
